Categories Earnings, Finance, LATEST

Earnings: Citigroup (C) Q4 profit beats estimates; revenue edges up

Citigroup Inc. (NYSE: C) on Friday said its fourth-quarter profit decreased despite modest growth in revenues. However, the numbers topped the market’s projections.

Citigroup Q4 2021 earnings infographic

Fourth-quarter net profit declined to $3.2 billion or $1.46 per share from $4.31 billion or $1.92 per share last year but came in above the consensus forecast. Excluding the impact of Asia divestitures, earnings per share were $1.99, up 4%.

Meanwhile, total revenues moved up 1% annually to $17 billion and topped expectations, reflecting active customer engagement amid increased consumer and corporate confidence. At $92.21, book value per share was up 7% year-over-year.


Read management/analysts’ comments on Citigroup’s Q4 earnings


Shares of Citigroup dropped early Friday immediately after the announcement. The stock has gained about 6% in the past twelve months.

Prior Performance

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

WMT Earnings: All you need to know about Walmart’s Q2 2023 earnings results

Walmart Inc. (NYSE: WMT) reported second quarter 2023 earnings results today. Total revenue increased 8.4% year-over-year to $152.9 billion. Revenues grew 9.1% in constant currency. Consolidated net income attributable to

Rivian (RIVN) reaffirms production goals. Will it be a smooth ride?

The evolution of the electric vehicle industry accelerated in recent years even as innovations in battery technology and affordability brought EVs into the mainstream. Encouraged by the success of market

Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term

Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a mixed sentiment surrounding the company’s growth prospects. Pfizer has benefited

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top